Applying AI-powered digital pathology for personalized drug response prediction
31 Oct 2024
Drug Response Prediction
- How can digital pathology and AI be utilized for patient selection and pharmacodynamic biomarker discovery, development, and deployment?
- What are the relative benefits of H&E, multiplex IF, and IHC-based digital pathology biomarkers throughout the stages of drug development and for clinical implementation?
- What are the applications, opportunities and challenges of AI-powered digital pathology to support drug development?
- Where is the AI-digital pathology field headed next?
Industry Experts
